B. Linju Yen

Publications

• Interleukin-25 Mediates Transcriptional Control of PD-L1 Via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses
  Stem Cell Reports. Sep, 2015  |   Pubmed ID: 26321145
• Transplantation of Human Placenta-derived Multipotent Stem Cells Reduces Ischemic Brain Injury in Adult Rats
  Cell Transplantation. 2015  |   Pubmed ID: 25668287
• Human Placenta-Derived Multipotent Cells (hPDMCs) Modulate Cardiac Injury: From Bench to Small & Large Animal Myocardial Ischemia Studies
  Cell Transplantation. Jan, 2015  |   Pubmed ID: 25621818
• Induction of Immunomodulatory Monocytes by Human Mesenchymal Stem Cell-derived Hepatocyte Growth Factor Through ERK1/2
  Journal of Leukocyte Biology. Aug, 2014  |   Pubmed ID: 24714552
• Neocartilage Formation from Mesenchymal Stem Cells Grown in Type II Collagen-hyaluronan Composite Scaffolds
  Differentiation; Research in Biological Diversity. Nov-Dec, 2013  |   Pubmed ID: 24462469
• Multipotent Human Mesenchymal Stromal Cells Mediate Expansion of Myeloid-derived Suppressor Cells Via Hepatocyte Growth Factor/c-met and STAT3
  Stem Cell Reports. 2013  |   Pubmed ID: 24052949
• The Role of RhoA Kinase Inhibition in Human Placenta-derived Multipotent Cells on Neural Phenotype and Cell Survival
  Biomaterials. Apr, 2013  |   Pubmed ID: 23410680
• H2O2 Accumulation Mediates Differentiation Capacity Alteration, but Not Proliferative Decline, in Senescent Human Fetal Mesenchymal Stem Cells
  Antioxidants & Redox Signaling. May, 2013  |   Pubmed ID: 23088254
• 14-3-3σ Regulates β-catenin-mediated Mouse Embryonic Stem Cell Proliferation by Sequestering GSK-3β
  PloS One. 2012  |   Pubmed ID: 22768254
• Current Applications of Human Pluripotent Stem Cells: Possibilities and Challenges
  Cell Transplantation. 2012  |   Pubmed ID: 22449556
• Immunomodulatory Properties of Human Adult and Fetal Multipotent Mesenchymal Stem Cells
  Journal of Biomedical Science. 2011  |   Pubmed ID: 21762539
• Surface Expression of HLA-G is Involved in Mediating Immunomodulatory Effects of Placenta-derived Multipotent Cells (PDMCs) Towards Natural Killer Lymphocytes
  Cell Transplantation. 2011  |   Pubmed ID: 21669042
• Endogenous KLF4 Expression in Human Fetal Endothelial Cells Allows for Reprogramming to Pluripotency with Just OCT3/4 and SOX2--brief Report
  Arteriosclerosis, Thrombosis, and Vascular Biology. Oct, 2010  |   Pubmed ID: 20689077
• Upregulation of SOX9 in Lung Adenocarcinoma and Its Involvement in the Regulation of Cell Growth and Tumorigenicity
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2010  |   Pubmed ID: 20651055
• Brief Report--human Embryonic Stem Cell-derived Mesenchymal Progenitors Possess Strong Immunosuppressive Effects Toward Natural Killer Cells As Well As T Lymphocytes
  Stem Cells (Dayton, Ohio). Feb, 2009  |   Pubmed ID: 18988708
• Placenta-derived Multipotent Cells Differentiate into Neuronal and Glial Cells in Vitro
  Tissue Engineering. Part A. Jan, 2008  |   Pubmed ID: 18333820
• Multilineage Differentiation and Characterization of the Human Fetal Osteoblastic 1.19 Cell Line: a Possible in Vitro Model of Human Mesenchymal Progenitors
  Stem Cells (Dayton, Ohio). Jan, 2007  |   Pubmed ID: 17204605
• Placenta-derived Multipotent Cells Exhibit Immunosuppressive Properties That Are Enhanced in the Presence of Interferon-gamma
  Stem Cells (Dayton, Ohio). Nov, 2006  |   Pubmed ID: 17071860
• Increased High Sensitivity C-reactive Protein and Neutrophil Count Are Related to Increased Standard Cardiovascular Risk Factors in Healthy Chinese Men
  International Journal of Cardiology. Jun, 2006  |   Pubmed ID: 16305810
• Isolation of Multipotent Cells from Human Term Placenta
  Stem Cells (Dayton, Ohio). 2005  |   Pubmed ID: 15625118